Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L6VM
|
|||
Former ID |
DNC010398
|
|||
Drug Name |
2-fluorophenyl 4-(dodecyloxy)phenylcarbamate
|
|||
Synonyms |
CHEMBL599488; 2-fluorophenyl 4-(dodecyloxy)phenylcarbamate
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C25H34FNO3
|
|||
Canonical SMILES |
CCCCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F
|
|||
InChI |
1S/C25H34FNO3/c1-2-3-4-5-6-7-8-9-10-13-20-29-22-18-16-21(17-19-22)27-25(28)30-24-15-12-11-14-23(24)26/h11-12,14-19H,2-10,13,20H2,1H3,(H,27,28)
|
|||
InChIKey |
WEDCHEHVZVVAIL-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.